Arthur C Ouwehand
Ouwehand, Arthur.
Ouwehand, Arthur C.
VIAF ID: 71650201 (Personal)
Permalink: http://viaf.org/viaf/71650201
Preferred Forms
- 100 0 _ ‡a Arthur C Ouwehand
- 200 _ | ‡a Ouwehand ‡b Arthur
-
-
- 100 1 _ ‡a Ouwehand, Arthur
- 100 1 _ ‡a Ouwehand, Arthur
- 100 1 _ ‡a Ouwehand, Arthur
-
-
- 100 1 _ ‡a Ouwehand, Arthur C.
-
- 100 1 _ ‡a Ouwehand, Arthur C.
-
4xx's: Alternate Name Forms (3)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Development of dietary soluble fibres by enzymatic synthesis and assessment of their digestibility in in vitro, animal and randomised clinical trial models. | |
Differences in composition and mucosal adhesion of bifidobacteria isolated from healthy adults and healthy seniors. | |
Displacement of bacterial pathogens from mucus and Caco-2 cell surface by lactobacilli. | |
Dose-response effect of Bifidobacterium lactis HN019 on whole gut transit time and functional gastrointestinal symptoms in adults | |
Dose-Response Recovery of Probiotic Strains in Simulated Gastro-Intestinal Passage | |
The Effect of Donor Human Milk Fortification on The Adhesion of Probiotics In Vitro | |
The effect of feeding essential oils on broiler performance and gut microbiota. | |
Effect of four probiotic strains and Escherichia coli O157:H7 on tight junction integrity and cyclo-oxygenase expression. | |
Effect of orally administered non-viable Lactobacillus cells on murine humoral immune responses | |
The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study. | |
Effect of yogurt containing polydextrose, Lactobacillus acidophilus NCFM and Bifidobacterium lactis HN019: a randomized, double-blind, controlled study in chronic constipation | |
Effectiveness of Multistrain Versus Single-strain Probiotics: Current Status and Recommendations for the Future. | |
Effects of lactose on colon microbial community structure and function in a four-stage semi-continuous culture system. | |
Enzyme catalysed production of sialylated human milk oligosaccharides and galactooligosaccharides by Trypanosoma cruzi trans-sialidase. | |
Fecal Recovery of Probiotics Administered as a Multi-Strain Formulation during Antibiotic Treatment | |
The fermentation of polydextrose in the large intestine and its beneficial effects. | |
Gastroesophageal Reflux Disease and Probiotics: A Systematic Review | |
Gastrointestinal microbiology | |
Gut microbiota of healthy elderly NSAID users is selectively modified with the administration of Lactobacillus acidophilus NCFM and lactitol | |
Human ileostomy glycoproteins as a model for small intestinal mucus to investigate adhesion of probiotics | |
The hygiene hypothesis of atopic disease--an extended version. | |
Immune enhancement in rainbow trout (Oncorhynchus mykiss) by potential probiotic bacteria (Lactobacillus rhamnosus). | |
Impact of polydextrose on the faecal microbiota: a double-blind, crossover, placebo-controlled feeding study in healthy human subjects. | |
Implications of nomenclature--and on the interpretation. | |
Improved artificial saliva for studying the cariogenic effect of carbohydrates | |
In vitro inhibition of adhesion of Escherichia coli | |
In vivo safety assessment of two Bifidobacterium longum strains. | |
Inflammation markers and malnutrition as risk factors for infections and impaired health-related quality of life among older nursing home residents. | |
Influence of a probiotic mixture on antibiotic induced microbiota disturbances | |
Influence of Lactitol and Psyllium on Bowel Function in Constipated Indian Volunteers: A Randomized, Controlled Trial. | |
Ingestion of polydextrose increase the iron absorption in rats submitted to partial gastrectomy | |
Intestinal Bifidobacterium species induce varying cytokine production | |
Intestinal microbiota is altered in patients with colon cancer and modified by probiotic intervention. | |
Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment. | |
Irritable bowel syndrome symptom severity improves equally with probiotic and placebo | |
Lactic acid bacteria : microbiological and functional aspects | |
Lactobacilli vaginal colonisation after oral consumption of Respecta(®) complex: a randomised controlled pilot study. | |
Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors | |
Lactobacillus acidophilus supplementation in human subjects and their resistance to enterotoxigenic Escherichia coli infection. | |
Lactobacillus species causing obesity in humans: where is the evidence? | |
Measurement of bacterial adhesion-in vitro evaluation of different methods. | |
Metabolic Fate of 13C-Labeled Polydextrose and Impact on the Gut Microbiome: A Triple-Phase Study in a Colon Simulator. | |
Microbial-gut interactions in health and disease. Probiotics. | |
Microbial interactions to intestinal mucosal models | |
Microbiota composition of the intestinal mucosa: association with fecal microbiota? | |
Modulation of the host response by probiotic Lactobacillus brevis CD2 in experimental gingivitis. | |
Monitoring immune modulation by nutrition in the general population: identifying and substantiating effects on human health. | |
The mucus binding of Bifidobacterium lactis Bb12 is enhanced in the presence of Lactobacillus GG and Lact. delbrueckii subsp. bulgaricus | |
Normative values for stool frequency and form using Rome III diagnostic criteria for functional constipation in adults: systematic review with meta-analysis | |
Novel approaches to the nutritional management of the allergic infant | |
Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. | |
Performance of bifidobacteria in oat-based media | |
Phenotypic differences between commercial Lactobacillus rhamnosus GG and L. rhamnosus strains recovered from blood | |
Polydextrose: Physiological Function, and Effects on Health | |
Potential of enterococci isolated from horses. | |
Probiotic approach to prevent antibiotic resistance. | |
Probiotic bacteria may become dormant during storage. | |
Probiotic use in at-risk populations | |
Probiotics: an overview of beneficial effects. | |
Probiotics for the skin: a new area of potential application? | |
Probiotics from an industrial perspective | |
Probiotics reduce symptoms of antibiotic use in a hospital setting: a randomized dose response study | |
Probiotics: time to move beyond Metchnikoff? | |
The Production and Delivery of Probiotics: A Review of a Practical Approach | |
Resected human colonic tissue: new model for characterizing adhesion of lactic acid bacteria. | |
Safety assessment of Lactobacillus strains: presence of putative risk factors in faecal, blood and probiotic isolates. | |
Safety evaluation of AB-LIFE(®) (Lactobacillus plantarum CECT 7527, 7528 and 7529): Antibiotic resistance and 90-day repeated-dose study in rats. | |
Safety evaluation of HOWARU® Restore (Lactobacillus acidophilus NCFM, Lactobacillus paracasei Lpc-37, Bifidobacterium animalis subsp. lactis Bl-04 and B. lactis Bi-07) for antibiotic resistance, genomic risk factors, and acute toxicity. | |
Selection of enterococci for potential canine probiotic additives. | |
Simulating colonic survival of probiotics in single-strain products compared to multi-strain products. | |
Specific Bifidobacterium strains isolated from elderly subjects inhibit growth of Staphylococcus aureus. | |
Staphylococcus aureus adheres to human intestinal mucus but can be displaced by certain lactic acid bacteria. | |
Stimulation of the secretion of pro-inflammatory cytokines by Bifidobacterium strains. | |
Streptococcus alactolyticus is the dominating culturable lactic acid bacterium species in canine jejunum and feces of four fistulated dogs. | |
Streptococcus mutans, caries and simulation models. | |
Synbiotic effects of lactitol and Lactobacillus acidophilus NCFM™ in a semi-continuous colon fermentation model. | |
Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics | |
Use of a probiotic Bifidobacterium in a dry food matrix, an in vivo study | |
The use of in vitro model systems to study dental biofilms associated with caries: a short review | |
Xylitol's Health Benefits beyond Dental Health: A Comprehensive Review | |
Xylo-oligosaccharides alone or in synbiotic combination with Bifidobacterium animalis subsp. lactis induce bifidogenesis and modulate markers of immune function in healthy adults: a double-blind, placebo-controlled, randomised, factorial cross-over s | |
Xylo-oligosaccharides and lactitol promote the growth of Bifidobacterium lactis and Lactobacillus species in pure cultures. |